Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

3.9K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

6.5K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.5K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.2K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

6.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

5.9K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interfacial-Electronegativity-Induced Near-Surface Tetrahedral Reconstruction Enables One-Step Upcycling of Spent LiFePO<sub>4</sub> for High-Rate and Long-Life Pouch Cells.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Translating priority effects and niche engineering into rational microbiome therapeutics across the gut-lung axis.

Frontiers in microbiology·2026
Same author

Measuring airway compliance of pulmonary fibrosis by endobronchial optical coherence elastography.

PloS one·2026
Same author

Regulation of T Cell Senescence in Health and Diseases.

Immune network·2026
Same author

A novel surgical T staging system for recurrent nasopharyngeal carcinoma: advancing prognostic accuracy and clinical applicability.

Journal of neurosurgery·2026
Same author

Theoretical investigation of momentum-dependent carrier-carrier scattering from crystal-strong laser interaction.

Optics express·2026

Related Experiment Video

Updated: Aug 31, 2025

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
08:04

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method

Published on: October 23, 2018

19.1K

AMPK suppresses Th2 cell responses by repressing mTORC2.

Mahesh Pandit1, Maheshwor Timilshina1, Ye Gu1

  • 1College of Pharmacy, Yeungnam University, Gyeongsan, 38541, Republic of Korea.

Experimental & Molecular Medicine
|August 23, 2022
PubMed
Summary

AMP-activated protein kinase (AMPK) inhibits T helper 2 (Th2) cell differentiation in allergic inflammation by repressing mTORC2 signaling. This finding suggests AMPK as a potential therapeutic target for Th2 cell-associated diseases.

More Related Videos

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

9.2K
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

237

Related Experiment Videos

Last Updated: Aug 31, 2025

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
08:04

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method

Published on: October 23, 2018

19.1K
Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

9.2K
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

237

Area of Science:

  • Immunology
  • Metabolic pathways
  • Cellular signaling

Background:

  • Allergic inflammation is driven by T helper 2 (Th2) cells.
  • The metabolic regulation of Th2 cell differentiation is not fully understood.
  • Intracellular energy sensors play a role in immune cell function.

Purpose of the Study:

  • To investigate the role of AMP-activated protein kinase (AMPK) and Sirtuin 1 (Sirt1) in Th2 cell differentiation and allergic inflammation.
  • To elucidate the molecular mechanisms linking AMPK signaling to Th2 cell responses.

Main Methods:

  • Utilized T-cell-specific AMPK or Sirtuin 1 (Sirt1)-knockout mouse models.
  • Induced allergic inflammation and assessed Th2 cell responses.
  • Administered AICAR (AMPK activator) and genetically manipulated mTORC2 components.

Main Results:

  • AMPK and Sirt1 deficiency exacerbated allergic inflammation and increased Th2 cell responses.
  • AICAR treatment ameliorated allergic inflammation.
  • AMPK repressed mTORC2, leading to reduced SOCS5 expression and enhanced IL-4/STAT6/GATA3-mediated Th2 differentiation.
  • Rictor deletion in Sirt1-deficient mice reversed allergic exacerbation.

Conclusions:

  • AMPK signaling in CD4+ T cells inhibits Th2 cell differentiation by suppressing mTORC2.
  • AMPK acts as a negative regulator of Th2 cell-mediated allergic inflammation.
  • AMPK represents a potential therapeutic target for Th2 cell-associated diseases.